Related Experiment Video

Updated: Aug 8, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

[Molecular therapy targets in lung cancer]

Yannick Le Guen1, Laure Sabatier, Thierry Le Chevalier

  • 1Département de médecine, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif, France.

Bulletin Du Cancer
|January 13, 2004
PubMed

Insights

Molecular targeted therapies show promise for lung cancer by targeting specific cancer cell abnormalities. This review covers key pathways, targeted drugs, clinical trials, and challenges in developing these novel lung cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Context:

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Molecular targeted therapies represent a paradigm shift in cancer treatment, focusing on specific molecular alterations.
  • Understanding the molecular pathways driving lung cancer is crucial for developing effective therapies.

Purpose:

  • To review major molecular pathways involved in lung cancer progression, including tumor cell growth, apoptosis, angiogenesis, and invasion.
  • To describe the landscape of targeted therapies that interact with these critical pathways in lung cancer.
  • To provide an overview of clinical trials and discuss challenges associated with the development of targeted therapies for lung cancer.

Summary:

  • Targeted therapies aim to inhibit specific molecular abnormalities unique to cancer cells, offering a more precise approach than traditional chemotherapy.
  • Key pathways such as cell growth, programmed cell death (apoptosis), new blood vessel formation (angiogenesis), and metastasis (invasion) are critical targets.
  • The review synthesizes information on various targeted agents, their mechanisms of action, and their evaluation in clinical trials for lung cancer.

Impact:

  • Highlights the potential of molecular targeted therapies to improve outcomes for lung cancer patients.
  • Identifies challenges in the development and clinical application of targeted therapies, such as resistance mechanisms and patient selection.
  • Provides a comprehensive resource for researchers and clinicians interested in the advancement of targeted lung cancer treatments.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...